FindTrial
Sign In

To Identify the proper method of preparation and clinical results of Tavaksiri satva

PHARMACEUTICAL & ANALYTICAL STUDY OF SATVA KALPANA W.S.R TO TAVAKSIRI AND ITS EFFICACY VALIDATION IN AMLAPITTA CHIKITSA - NILL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084744
Enrollment
150
Registered
2025-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

None listed

Sponsors

Dr Rikal Kailas
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient aged between 18-50 years. Patient of either sex are taken. Patients of classical Amlapitta symptoms irrespective of gender cast occupation and economical status.

Exclusion criteria

Exclusion criteria: Patients below 18 years and above 50 years. Patients suffering from other systemic disorders other than Amlapitta. Lactating and pregnant woman. Amlapitta patients along with metabolic diseases such as Diabetes and Hypertension.

Design outcomes

Primary

MeasureTime frame
Amlapitta can be cured after proper consumption of Tavakshiri SatvaTimepoint: 30 days—

Secondary

MeasureTime frame
As Tavakshiri is a medicine of herbal origin may not cause any harmful effectsTimepoint: 30 days—

Countries

India

Contacts

Public ContactDr RIKAL KAILAS

Parul Institute of Ayurveda

prasanna.mathad86177@paruluniversity.ac.in9448630285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026